Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults - Concepedia

Concepedia

Publication | Open Access

Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults

DOI Full Paper Access

50

Citations

12

References

2024

Year

Christine A. Shaw, Brandon Essink, Charles Harper, Runa Mithani, Archana Kapoor, Rakesh Dhar, Lauren Wilson, Ruiting Guo, Catherine A. Panozzo, Eleanor Wilson,

The Journal of Infectious Diseases

Abstract

NCT04528719 (ClinicalTrials.gov).

References

	Year	Citations

Page 1